The COVID–19 pandemic has accelerated the uptake of digitalised clinical trials and new technologies. Whilst stakeholders have been frantically trying to provide and maintain access to clinical trials they are also dealing with a lack of clarity and understanding of roles, responsibilities and expectations. This summit provides an opportunity to bring stakeholders together to discuss the benefits of digitalisation, to highlight challenges and to work together to achieve a united and consistent approach. Topics covered include:
Who should attend?
The summit is open to anyone interested in understanding the current landscape of digitalisation of clinical trials and what the future holds.
Topics to be discussed
Digitalised trials: Back to basics: demystifying the jargon and defining the components (stakeholders, types – roles and responsibilities)
Implementation: Key issues - recruitment, retention, diversity, workforce capacity, vendors, phases of research, therapeutic area
Risk, oversight and quality considerations: QA, QC and GCP
Technology: Technology as an enabler - ePRO, eCOA, e-Consent, study start up, wearables, virtual visits, internal systems
View summit Sponsors and exhibitors
Registrations are now closed.
%20(2).jpg)
-%20Ausbiotech24.jpg)
